{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:06:30Z","timestamp":1792800390602,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T00:00:00Z","timestamp":1532736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572428"],"award-info":[{"award-number":["81572428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China (CN)","award":["81770539"],"award-info":[{"award-number":["81770539"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12902-018-0274-y","type":"journal-article","created":{"date-parts":[[2018,7,28]],"date-time":"2018-07-28T03:51:06Z","timestamp":1532749866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Variability of the Ki-67 proliferation index in gastroenteropancreatic neuroendocrine neoplasms - a single-center retrospective study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-9944","authenticated-orcid":false,"given":"Huiying","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoqun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,28]]},"reference":[{"issue":"6","key":"274_CR1","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s00268-014-2451-0","volume":"38","author":"HC Miller","year":"2014","unstructured":"Miller HC, Drymousis P, Flora R, Goldin R, Spalding D, Frilling A. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease. World J Surg. 2014;38(6):1353\u201361.","journal-title":"World J Surg"},{"issue":"11","key":"274_CR2","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.ejso.2014.06.016","volume":"40","author":"S Singh","year":"2014","unstructured":"Singh S, Hallet J, Rowsell C, Law CH. Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014;40(11):1517\u201322.","journal-title":"European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology"},{"issue":"5","key":"274_CR3","first-page":"362","volume":"63","author":"W Foltyn","year":"2012","unstructured":"Foltyn W, Zajecki W, Marek B, Kajdaniuk D, Sieminska L, Zemczak A, Kos-Kudla B. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours. Endokrynologia Polska. 2012;63(5):362\u20136.","journal-title":"Endokrynologia Polska"},{"key":"274_CR4","volume-title":"Lyon: IARC press","author":"PSL Kleihues","year":"2004","unstructured":"Kleihues PSL. World Health Organization classification of Tumours. Pathology and genetics of endocrine organs. In: Lyon: IARC press; 2004."},{"key":"274_CR5","unstructured":"Bosman FT CF, Hruban RH et al: WHO Classification of Tumours of the Digestive System, 4th edition. Geneva, Switzerland: WHO Press 2010, ISBN978\u201392\u2013832\u20132432\u20137."},{"issue":"9","key":"274_CR6","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1038\/bjc.2013.156","volume":"108","author":"MS Khan","year":"2013","unstructured":"Khan MS, Luong TV, Watkins J, Toumpanakis C, Caplin ME, Meyer T. A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms. Br J Cancer. 2013;108(9):1838\u201345.","journal-title":"Br J Cancer"},{"issue":"12","key":"274_CR7","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1097\/PAS.0b013e318272ff77","volume":"36","author":"V Adsay","year":"2012","unstructured":"Adsay V. Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count. Am J Surg Pathol. 2012;36(12):1743\u20136.","journal-title":"Am J Surg Pathol"},{"issue":"18","key":"274_CR8","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, et al. One hundred years after \"carcinoid\": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008;26(18):3063\u201372.","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"issue":"5","key":"274_CR9","first-page":"337","volume":"125","author":"E Lewkowicz","year":"2015","unstructured":"Lewkowicz E, Trofimiuk-Muldner M, Wysocka K, Pach D, Kieltyka A, Stefanska A, Sowa-Staszczak A, Tomaszewska R, Hubalewska-Dydejczyk A. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center. Polskie Archiwum Medycyny Wewnetrznej. 2015;125(5):337\u201346.","journal-title":"Polskie Archiwum Medycyny Wewnetrznej"},{"key":"274_CR10","doi-asserted-by":"crossref","unstructured":"Scarpa A, Mantovani W, Capelli P, Beghelli S, Boninsegna L, Bettini R, Panzuto F, Pederzoli P. Delle Fave G, Falconi M. pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc. 2010;23(6):824\u201333.","DOI":"10.1038\/modpathol.2010.58"},{"issue":"5","key":"274_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1159\/000439434","volume":"103","author":"F Grillo","year":"2016","unstructured":"Grillo F, Albertelli M, Brisigotti MP, Borra T, Boschetti M, Fiocca R, Ferone D, Mastracci L. Grade increases in Gastroenteropancreatic neuroendocrine tumor metastases compared to the primary tumor. Neuroendocrinology. 2016;103(5):452\u20139.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"274_CR12","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1053\/j.semdp.2013.06.005","volume":"30","author":"Z Yang","year":"2013","unstructured":"Yang Z, Tang LH, Klimstra DS. Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues. Semin Diagn Pathol. 2013;30(3):186\u201396.","journal-title":"Semin Diagn Pathol"},{"issue":"4","key":"274_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/CCO.0000000000000299","volume":"28","author":"M Cives","year":"2016","unstructured":"Cives M, Soares HP, Strosberg J. Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials. Curr Opin Oncol. 2016;28(4):359\u201366.","journal-title":"Curr Opin Oncol"},{"issue":"10","key":"274_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T, Yao JC. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA oncology. 2017;3(10):1335\u201342.","journal-title":"JAMA oncology"},{"issue":"4","key":"274_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.humpath.2011.06.011","volume":"43","author":"D Dhall","year":"2012","unstructured":"Dhall D, Mertens R, Bresee C, Parakh R, Wang HL, Li M, Dhall G, Colquhoun SD, Ines D, Chung F, et al. Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal neuroendocrine tumors. Hum Pathol. 2012;43(4):489\u201395.","journal-title":"Hum Pathol"},{"issue":"1","key":"274_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S1470-2045(07)70410-2","volume":"9","author":"IM Modlin","year":"2008","unstructured":"Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, et al. Gastroenteropancreatic neuroendocrine tumours. The Lancet Oncology. 2008;9(1):61\u201372.","journal-title":"The Lancet Oncology"},{"issue":"2","key":"274_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1159\/000335629","volume":"95","author":"UF Pape","year":"2012","unstructured":"Pape UF, Perren A, Niederle B, Gross D, Gress T, Costa F, Arnold R, Denecke T, Plockinger U, Salazar R, et al. ENETS consensus guidelines for the management of patients with neuroendocrine neoplasms from the jejuno-ileum and the appendix including goblet cell carcinomas. Neuroendocrinology. 2012;95(2):135\u201356.","journal-title":"Neuroendocrinology"},{"key":"274_CR18","volume-title":"Applied immunohistochemistry & molecular morphology : AIMM","author":"I Kumler","year":"2016","unstructured":"Kumler I, Balslev E, Knop AS, Brunner N, Klausen TW, Jespersen SS, Nielsen SL, Nielsen DL. Expression patterns of biomarkers in primary tumors and corresponding metastases in breast Cancer. In: Applied immunohistochemistry & molecular morphology : AIMM; 2016."},{"key":"274_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2015.10.017","volume":"53","author":"Y Yamazaki","year":"2016","unstructured":"Yamazaki Y, Nakamura Y, Shibahara Y, Konosu-Fukaya S, Sato N, Kubota-Nakayama F, Oki Y, Baba S, Midorikawa S, Morimoto R, et al. Comparison of the methods for measuring the Ki-67 labeling index in adrenocortical carcinoma: manual versus digital image analysis. Hum Pathol. 2016;53:41\u201350.","journal-title":"Hum Pathol"},{"issue":"6","key":"274_CR20","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1118\/1.4949003","volume":"43","author":"NA Valous","year":"2016","unstructured":"Valous NA, Lahrmann B, Halama N, Bergmann F, Jager D, Grabe N. Spatial intratumoral heterogeneity of proliferation in immunohistochemical images of solid tumors. Med Phys. 2016;43(6):2936\u201347.","journal-title":"Med Phys"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-018-0274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-018-0274-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-018-0274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T00:37:02Z","timestamp":1568939822000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-018-0274-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,28]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/s12902-018-0274-y","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,28]]},"assertion":[{"value":"4 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the ethics committee of Tongji Medical College, Huazhong University of Science and Technology (IORG No: IORG0003571), and performed in accordance with the Declaration of Helsinki. As it was a retrospective study, all data were collected from a medical records system. Therefore, the study was exempt from the requirement to obtain individual informed consent, based on the Ethical Guidelines of the Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"51"}}